Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 3

2(40.0%)

Phase 1

1(20.0%)

5Total

Phase 2(2)

Phase 3(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00988533Phase 1Completed

A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age

Role: lead

NCT01066585Phase 3Completed

A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation

Role: lead

NCT01068158Phase 3Completed

A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

Role: lead

NCT00994422Phase 2Completed

Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

Role: lead

NCT00857948Phase 2Completed

Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation

Role: lead

All 5 trials loaded